# A Study to Evaluate the Safety, Tolerability and Efficacy of LB1148 for Subjects Undergoing Elective Bowel Resection

> **NCT04100447** · PHASE1 · COMPLETED · sponsor: **Ronald Hurst, MD, FACS** · enrollment: 11 (actual)

## Conditions studied

- Adhesions
- Ileus

## Interventions

- **DRUG:** Tranexamic Acid

## Key facts

- **NCT ID:** NCT04100447
- **Lead sponsor:** Ronald Hurst, MD, FACS
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-05
- **Primary completion:** 2020-03-20
- **Final completion:** 2020-12-01
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2020-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04100447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04100447, "A Study to Evaluate the Safety, Tolerability and Efficacy of LB1148 for Subjects Undergoing Elective Bowel Resection". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04100447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*